nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral - a podcast by ReachMD

from 2021-03-31T00:00

:: ::

CME credits: 0.25

Valid until: 31-03-2022

Claim your CME credit at https://reachmd.com/programs/cme/namd-and-rvo-understanding-the-impact-on-patient-lives-and-the-need-for-timely-diagnosis-and-referral/12386/



Approximately 2 million individuals in the United States are living with age-related macular degeneration (AMD), and another 1.6 million are living with retinal vein occlusion (RVO). These numbers are increasing daily due to an aging population and prevalence of risk factors. There have been many advances in treatment, but what else can you be doing to prevent vision loss in your patients?

In this activity, Dr. Emily Chew speaks with Drs. Neil Bressler, Joseph Coney, and Steven Ferrucci to examine the evidence around early diagnosis, referral, and treatment of AMD and RVO and the impact of these diseases on patients’ lives.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD